William A. Curran

Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725 million in cash. Total payments to Corvidia Therapeutics shareholders…

Davis Polk advised the representatives of the several underwriters, in connection with the initial public offering of 103,500,000 units of Foley Trasimene Acquisition Corp., including…

Davis Polk advised the underwriters in connection with the offering of $1.75 billion aggregate principal amount of 1.050% bonds due May 21, 2027 issued by the Province of Ontario. The Davis…

Davis Polk advised the underwriters in connection with the offering of $2.25 billion aggregate principal amount of 1.000% bonds due May 20, 2025, issued by the Province of Alberta. The…

Davis Polk advised the representatives of the several underwriters in connection with the $13.3 billion secondary offering of 31,628,573 shares of common stock of BlackRock, Inc. by a…

Davis Polk advised Verisk Analytics, Inc. on its SEC-registered offering of $500 million aggregate principal amount of 3.625% senior notes due 2050.  Verisk is a leading data analytics…

Davis Polk is advising Reliance Industries Limited and Jio Platforms Limited in connection with Vista Equity Partners’ investment of ₹11,367 crore into Jio Platforms. The…

Davis Polk advised the underwriter in connection with the initial public offering of 30,000,000 units of Sustainable Opportunities Acquisition Corp. for aggregate proceeds of $300…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $750 million of its 2.250% senior notes due 2030. MMC will use the net proceeds…

Davis Polk advised the deal managers, in connection with a Rule 144A and Regulation S offering by Central American Bank for Economic Integration (“CABEI”) of $750 million aggregate…